Disparate Outcomes from Applying U.K. and U.S. Osteoporosis Treatment Guidelines-Reference-Cited by-同舟云学术

Disparate Outcomes from Applying U.K. and U.S. Osteoporosis Treatment Guidelines

Published:2010-04-01 Issue:4 Volume:95 Page:1856-1860
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Bolland Mark J.¹,Grey Andrew¹

Affiliation:

1. Department of Medicine, University of Auckland, Auckland 1142, New Zealand

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/95/4/1856/10780736/jcem1856.pdf

Reference14 articles.

1. FRAX and its applications to clinical practice;Kanis;Bone,2009

2. A revised clinician’s guide to the prevention and treatment of osteoporosis;Dawson-Hughes;J Clin Endocrinol Metab,2008

3. Case finding for the management of osteoporosis with FRAX—assessment and intervention thresholds for the UK;Kanis;Osteoporos Int,2008

4. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK;Compston;Maturitas,2009

5. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA;Dawson-Hughes;Osteoporos Int,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eficacia clínica de los umbrales de intervención híbridos y dependientes de la edad basados en FRAX® en la población ecuatoriana;Revista de Osteoporosis y Metabolismo Mineral;2022-06

2. Unmet Needs and Challenges in Osteoporosis;New Horizons in Osteoporosis Management;2022

3. FRAX-based osteoporosis treatment guidelines for resource-poor settings in India;Archives of Osteoporosis;2021-04-14

4. Prophylaxis of Pain and Fractures within Feet in the Course of Osteoporosis: The Issue of Diagnosing;Pain Research and Management;2020-11-29

5. Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015;Frontiers in Pharmacology;2019-07-10